We should be able to devise a label that is easier to sell if we want our patent medicine to fly off the shelves, even if ours has the virtue of actually working.
But for the non-Anglo world -- that would be, oh, 95% of the world population, this label is smack on target and doesn't require to be changed one bit.
Corollary question: is it more important to promote the Anglo disease concept to the non-Anglo world (the rest of us) rather that to the UK/US/OZ? Europeans think a hundred miles is a long way. Americans think a hundred years is a long time.
